NEWS

Balancing Startup Risk and Reward
Balancing Startup Risk and Reward 11/07/2023
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM) 11/03/2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin
AbbVie Exercises Exclusive Right to Acquire Mitokinin 10/06/2023
Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer
Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer 10/02/2023
Regel Therapeutics Awarded $1 Million from HS Chau Women in Enterprising Science Program
Regel Therapeutics Awarded $1 Million from HS Chau Women in Enterprising Science Program 10/02/2023
Rezo Therapeutics Appoints Nadir Mahmood, Ph.D., as Chief Executive Officer
Rezo Therapeutics Appoints Nadir Mahmood, Ph.D., as Chief Executive Officer 09/21/2023
Exai Bio Presents Data Further Validating its Liquid Biopsy Platform at the 2023 World Conference on Lung Cancer
Exai Bio Presents Data Further Validating its Liquid Biopsy Platform at the 2023 World Conference on Lung Cancer 09/13/2023
Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors
Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors 09/13/2023
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms 08/28/2023
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform
ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform 08/22/2023
Foundery Announces Initial Close of Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies
Foundery Announces Initial Close of Inaugural Biotech Venture Creation Fund to Accelerate the Development of Novel Immunotherapies 08/22/2023
MindRhythm Announces Publication in JAMA Network Open of Novel Headset for Return to Play Decisions in Concussion
MindRhythm Announces Publication in JAMA Network Open of Novel Headset for Return to Play Decisions in Concussion 08/11/2023
Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death
Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death 08/11/2023
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction 08/08/2023
Scalable Care Inc signs landmark license agreement with UCSF to commercialize evidence-based mental health resources
Scalable Care Inc signs landmark license agreement with UCSF to commercialize evidence-based mental health resources 07/19/2023